Tylenol Lawsuit News: Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Tylenol in Treating Knee Osteoarthritis

Share Article

The study’s publication come as scores of people pursue Tylenol lawsuits over liver injuries allegedly caused by acetaminophen, the active ingredient in over-the-counter Tylenol products.

Free Case Review
The publication of this study comes as scores of people pursue Tylenol lawsuits over liver injuries that were allegedly caused by the acetaminophen in these over-the-counter products.

As Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) involving liver injuries continue to move forward in federal court, Bernstein Liebhard LLP notes that a new study is questioning the effectiveness of acetaminophen to treat knee osteoarthritis. Acetaminophen is the active ingredient in numerous pain killers, including over-the-counter Tylenol products.

According to a report from News 4 Jacksonville, the study appeared in the January 6th issue of the Annals of Internal Medicine, and compared 10 common treatments for knee osteoarthritis, including acetaminophen. Though it is the most commonly used over-the –counter remedy for the condition, the comparative study found that acetaminophen was the least effective in relieving this type of pain.*

“The publication of this study comes as scores of people pursue Tylenol lawsuits over liver injuries that were allegedly caused by the acetaminophen in these over-the-counter products. In light of this litigation, this study serves to remind that the benefits purportedly associated with the use of Tylenol may not always outweigh its risks,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Litigation
According to court documents, more than 160 Tylenol liver damage claims are currently pending in a litigation underway in the U.S. District Court, Eastern District of Pennsylvania, all of which allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide consumers with adequate warnings regarding the risks associated with the acetaminophen contained in Tylenol-brand medications. Among other things, the lawsuits claim that acetaminophen-induced liver damage related to Tylenol can occur even when the medication is used in accordance with label directions, and can be severe enough to result in hospitalization, liver transplantation, or death. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

In October 2014, a Consumer Reports investigation revealed that acetaminophen-induced liver damage sends more than 80,000 people to the emergency room every year.** In April 2013, the FDA announced that prescription drugs containing more than 325 milligrams of acetaminophen were no longer considered safe and were being voluntarily removed from the market. *** However, according to a Bloomberg.com report, over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen. ****

That same year, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.****

Individuals who suffered serious liver damage allegedly related to the acetaminophen in a Tylenol medication may be entitled to compensation for their injury-related damages. To learn more about the potential link between Tylenol and liver damage, please visit Bernstein Liebhard LLP's website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*news4jax.com/news/acetaminophen-least-effective-for-treating-knee-osteoarthritis-pain/30538602, News 4 Jax, January 5, 2015
**newsnet5.com/money/consumer/consumer-specialist/warning-about-acetaminophen-consumer-reports-investigates, Consumer Reports (via 5 ABC News) October 29, 2014
***latimes.com/science/sciencenow/la-sci-sn-extra-strength-acetaminophen-fda-20140428-story.html, LA Times, April 28, 2014
****bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website